Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Cipla inks investment pact with FIL Investments

The Indian Consumer Health Care (CHC) is a $4 billion market and is growing at a CAGR of 15 per cent. It is expected to be a $10 billion market by 2020.

The roughly $150 billion merger would see New York-based Pfizer redomicile in Ireland, where Botox-maker Allergan is registered.

The Swiss drug major said that a highly predictable IPR regime is needed for the Indian pharma industry to develop to the level of the US or Europe.
The Wall Street Journal said that the deal could be the biggest merger in the healthcare industry in already busy year.
SME banne